Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
2 "Eun-Jung Lee"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Inter-alpha Inhibitor H4 as a Potential Biomarker Predicting the Treatment Outcomes in Patients with Hepatocellular Carcinoma
Eun-Jung Lee, Seung-Hyun Yang, Kyoung-Jin Kim, Hyejung Cha, Seo Jin Lee, Ji-Hye Kim, Junkyu Song, Kyung-Hee Chun, Jinsil Seong
Cancer Res Treat. 2018;50(3):646-657.   Published online July 17, 2017
DOI: https://doi.org/10.4143/crt.2016.550
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Early prediction of treatment outcomes represents an essential step towards increased treatment efficacy and survival in patients with hepatocellular carcinoma (HCC). In this study, we performed two-dimensional electrophoresis (2-DE) followed by protein profiling to identify biomarkers predictive of therapeutic outcomes in patients with HCC who received liver-directed therapy (LDTx) involving local radiotherapy (RT), and studied the underlying mechanisms of the identified proteins.
Materials and Methods
2-DE analysis was conducted by pooling sera from patients with a good or poor prognosis; serum proteomic profiles of the two groups were compared and analyzed using matrixassisted laser desorption/ionization time-of-flight mass spectrometry. Identified proteins were confirmed via enzyme-linked immunosorbent assay. An invasion assay was performed after overexpression and knockdown of target protein in Huh7 cells.
Results
Levels of inter-alpha inhibitor H4 (ITIH4), fibrinogen gamma chain, keratin 9/1 complex, carbonic anhydrase I, and carbonmonoxyhemoglobin S were changed by more than 4-fold in response to LDTx. In particular, pre-LDTx ITIH4 expression was more than 5-fold higher in patients with a good prognosis, compared to patients with a poor prognosis. The migration ability of Huh7 cells was significantly suppressed and enhanced by ITIH4 overexpression and knockdown, respectively. The tumors of patients with HCC and a good prognosis expressed high levels of ITIH4, compared to those of patients with a poor prognosis.
Conclusion
Taken together, ITIH4 may be a potential therapeutic target that could inhibit cancer metastasis, as well as a prognostic marker for patients with HCC who are receiving LDTx.

Citations

Citations to this article as recorded by  
  • Mass spectrometry-based proteomics of cerebrospinal fluid in pediatric central nervous system malignancies: a systematic review with meta-analysis of individual patient data
    Christian Mirian, Maria Thastrup, René Mathiasen, Kjeld Schmiegelow, Jesper Velgaard Olsen, Ole Østergaard
    Fluids and Barriers of the CNS.2024;[Epub]     CrossRef
  • Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravis
    Christina B. Schroeter, Christopher Nelke, Frauke Stascheit, Niklas Huntemann, Corinna Preusse, Vera Dobelmann, Lukas Theissen, Marc Pawlitzki, Saskia Räuber, Alice Willison, Anna Vogelsang, Adela Della Marina, Hans-Peter Hartung, Nico Melzer, Felix F. Ko
    Acta Neuropathologica.2024;[Epub]     CrossRef
  • The function of the inter-alpha-trypsin inhibitors in the development of disease
    Xin-feng Zhang, Xiao-li Zhang, Li Guo, Yun-ping Bai, Yan Tian, Hua-you Luo
    Frontiers in Medicine.2024;[Epub]     CrossRef
  • Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasms of the Pancreas
    William A. Ziaziaris, Christopher S. H. Lim, Loretta Sioson, Anthony J. Gill, Jaswinder S. Samra, Sumit Sahni, Anubhav Mittal
    Cancer Medicine.2024;[Epub]     CrossRef
  • Characterization of the Limbal Epithelial Stem Cell Niche
    Isabel Y. Moreno, Arian Parsaie, Tarsis F. Gesteira, Vivien J. Coulson-Thomas
    Investigative Opthalmology & Visual Science.2023; 64(13): 48.     CrossRef
  • Leveraging Blood-Based Diagnostics to Predict Tumor Biology and Extend the Application and Personalization of Radiotherapy in Liver Cancers
    Franziska Hauth, Hannah J. Roberts, Theodore S. Hong, Dan G. Duda
    International Journal of Molecular Sciences.2022; 23(4): 1926.     CrossRef
  • Regulatory network identified by pulmonary transcriptome and proteome profiling reveals extensive change of tumor-related genes in microRNA-21 knockout mice
    Ge Luan, Ming Wang, Jing Yuan, Xiangting Bu, Jing Song, Chengshuo Wang, Luo Zhang
    Journal of Cancer Research and Clinical Oncology.2022; 148(8): 1919.     CrossRef
  • Identification of main influencing factors on the protein corona composition of PLGA and PLA nanoparticles
    Hendrik Spreen, Matthias Behrens, Dennis Mulac, Hans-Ulrich Humpf, Klaus Langer
    European Journal of Pharmaceutics and Biopharmaceutics.2021; 163: 212.     CrossRef
  • Clinical Assay for the Early Detection of Colorectal Cancer Using Mass Spectrometric Wheat Germ Agglutinin Multiple Reaction Monitoring
    I-Jung Tsai, Emily Chia-Yu Su, I-Lin Tsai, Ching-Yu Lin
    Cancers.2021; 13(9): 2190.     CrossRef
  • Liver-specific over-expression of Cripto-1 in transgenic mice promotes hepatocyte proliferation and deregulated expression of hepatocarcinogenesis-related genes and signaling pathways
    Yu Liu, Yan-Qing Li, Shi-Hao Huang, Yong-Long Li, Jia-Wei Xia, Jun-Shuang Jia, Fang Wei, Jia-Hong Wang, Guan-Qi Dai, Yu-Cai Wang, Xiao-Yan Li, Liu-Xin Han, Xiao-Ling Zhang, Xu-Dong Xiang, Wen-Tao Zhao, Dong Xiao, Xiao-Lin Lin
    Aging.2021; 13(17): 21155.     CrossRef
  • ITIH4 is a novel serum biomarker for early gastric cancer diagnosis
    Yingying Sun, Jie Jin, Hongyan Jing, Yingying Lu, Qingqing Zhu, Changjuan Shu, Qinghua Zhang, Dadao Jing
    Clinica Chimica Acta.2021; 523: 365.     CrossRef
  • The Alterations in Methylene Blue/Light-Treated Frozen Plasma Proteins Revealed by Proteomics
    Tiange Wu, Xiaoning Wang, Kai Ren, Xiaochen Huang, Jiankai Liu
    Transfusion Medicine and Hemotherapy.2021; 48(5): 298.     CrossRef
  • The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma
    Lucas Trevisan França de Lima, Daniel Broszczak, Xi Zhang, Kim Bridle, Darrell Crawford, Chamindie Punyadeera
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2020; 1874(2): 188451.     CrossRef
  • Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data
    Lazaro Hiram Betancourt, Krzysztof Pawłowski, Jonatan Eriksson, A. Marcell Szasz, Shamik Mitra, Indira Pla, Charlotte Welinder, Henrik Ekedahl, Per Broberg, Roger Appelqvist, Maria Yakovleva, Yutaka Sugihara, Kenichi Miharada, Christian Ingvar, Lotta Lund
    Scientific Reports.2019;[Epub]     CrossRef
  • Plasma Inter-Alpha-Trypsin Inhibitor Heavy Chains H3 and H4 Serve as Novel Diagnostic Biomarkers in Human Colorectal Cancer
    Xiao Jiang, Xiao-Yan Bai, Bowen Li, Yanan Li, Kangkai Xia, Miao Wang, Shujing Li, Huijian Wu
    Disease Markers.2019; 2019: 1.     CrossRef
  • 11,532 View
  • 243 Download
  • 18 Web of Science
  • 15 Crossref
Close layer
Overexpression of SOX2 Is Associated with Better Overall Survival in Squamous Cell Lung Cancer Patients Treated with Adjuvant Radiotherapy
Hong In Yoon, Kyu Hyun Park, Eun-Jung Lee, Ki Chang Keum, Chang Geol Lee, Chul Hoon Kim, Yong Bae Kim
Cancer Res Treat. 2016;48(2):473-482.   Published online August 12, 2015
DOI: https://doi.org/10.4143/crt.2015.116
AbstractAbstract PDFPubReaderePub
Purpose
The purpose of this study is to investigate the prognostic significance of SOX2 gene amplification and expression in patients with American Joint Committee on Cancer stage III lung squamous cell carcinoma (SCC) who underwent surgery followed by adjuvant radiotherapy.
Materials and Methods
Pathological specimens were obtained from 33 patients with stage III lung SCC treated with surgery followed by adjuvant radiotherapy between 1996 and 2008. SOX2 gene amplification and protein expression were analyzed using fluorescent in situ hybridization and immunohistochemistry, respectively. Patients were divided into two groups according to their SOX2 gene amplification and protein expression status. Kaplan-Meier estimates and a Cox proportional hazards model were used to identify the prognostic factors affecting patient survival.
Results
The median follow-up period for surviving patientswas 58 months (range, 5 to 102 months). SOX2 gene amplification was observed in 22 patients and protein overexpression in 26 patients. SOX2 overexpression showed significant association with SOX2 gene amplification (p=0.002). In multivariate analysis, SOX2 overexpression was a significant prognostic factor for overall survival (OS) (hazard ratios [HR], 0.1; 95% confidence interval [CI], 0.002 to 0.5; p=0.005) and disease-free survival (DFS) (HR, 0.15; 95% CI, 0.04 to 0.65; p=0.01). Age (HR, 0.33; 95% CI, 0.11 to 0.98; p=0.046) and total radiation dose (HR, 0.13; 95% CI, 0.02 to 0.7; p=0.02) were the independent prognostic factors for OS and DFS. Patients with SOX2 amplification did not show a longer OS (p=0.95) and DFS (p=0.48).
Conclusion
Our data suggested that SOX2 overexpression could be used as a positive prognostic factor in patients with stage III lung SCC receiving adjuvant radiotherapy.

Citations

Citations to this article as recorded by  
  • Identifying the key hub genes linked with lung squamous cell carcinoma by examining the differentially expressed and survival genes
    Anushka Pravin Chawhan, Norine Dsouza
    Molecular Genetics and Genomics.2024;[Epub]     CrossRef
  • Gene‐level dissection of chromosome 3q locus amplification in squamous cell carcinoma of the lung using the nCounter assay
    Taesung Jeon, Uk Jeen Oh, Jaeyoung Min, Chungyeul Kim
    Thoracic Cancer.2023; 14(26): 2635.     CrossRef
  • The role of SOX family members in solid tumours and metastasis
    Daniela Grimm, Johann Bauer, Petra Wise, Marcus Krüger, Ulf Simonsen, Markus Wehland, Manfred Infanger, Thomas J. Corydon
    Seminars in Cancer Biology.2020; 67: 122.     CrossRef
  • Blood-Based SOX2-Promoter Methylation in Relation to Exercise and PM2.5 Exposure among Taiwanese Adults
    Chun-Lang Su, Disline Manli Tantoh, Ying-Hsiang Chou, Lee Wang, Chien-Chang Ho, Pei-Hsin Chen, Kuan-Jung Lee, Oswald Ndi Nfor, Shu-Yi Hsu, Wen-Miin Liang, Yung-Po Liaw
    Cancers.2020; 12(2): 504.     CrossRef
  • Epithelial-Mesenchymal Transition in Skin Cancers: A Review
    Anastasia Hodorogea, Andreea Calinescu, Mihaela Antohe, Mihaela Balaban, Roxana Ioana Nedelcu, Gabriela Turcu, Daniela Adriana Ion, Ioana Anca Badarau, Catalin Mihai Popescu, Raluca Popescu, Cristiana Popp, Mirela Cioplea, Luciana Nichita, Ionela Hulea, A
    Analytical Cellular Pathology.2019; 2019: 1.     CrossRef
  • Towards understanding the mechanisms of actions of carcinoembryonic antigen‐related cell adhesion molecule 6 in cancer progression
    Balsam Rizeq, Zain Zakaria, Allal Ouhtit
    Cancer Science.2018; 109(1): 33.     CrossRef
  • Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells
    Ugo Testa, Germana Castelli, Elvira Pelosi
    Cancers.2018; 10(8): 248.     CrossRef
  • SOX2 knockdown inhibits the migration and invasion of basal cell carcinoma cells by targeting the SRPK1‑mediated PI3K/AKT signaling pathway
    Zhuo‑Ran Li, Yong Jiang, Jian‑Zhong Hu, Yang Chen, Quan‑Zhong Liu
    Oncology Letters.2018;[Epub]     CrossRef
  • Association of SOX2 and Nestin DNA amplification and protein expression with clinical features and overall survival in non-small cell lung cancer: A systematic review and meta-analysis
    Qingbao Li, Fang Liu, Yuan Zhang, Lei Fu, Cong Wang, Xuan Chen, Shanghui Guan, Xiangjiao Meng
    Oncotarget.2016; 7(23): 34520.     CrossRef
  • 11,942 View
  • 111 Download
  • 11 Web of Science
  • 9 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP